LLY Q3 2018 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

Q3 2018 Earnings

Reported November 6, 2018

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q3 2018	Q2 2018	Q3 2017	QoQ Change	YoY Change
Revenue	$5.3B	$5.6B	$5.7B	-5.0%	-6.2%
Op. Income	$1.5B	$1.6B	$1.2B	-10.3%	21.5%
Gross Margin	78.3%	77.9%	72.0%	0.4pp	6.3pp
Net Margin	21.7%	-4.7%	9.8%	26.3pp	11.8pp
EPS (Diluted)	$1.12	$-0.25	$0.50	548.0%	124.0%
Free Cash Flow	$1.8B	-$341M	$1.4B	634.8%	27.1%

Revenue Flow

Item	Amount
REVENUE	$5.3B
Cost of Revenue	$1.2B
GROSS PROFIT	$4.2B
R&D Expenses	$1.3B
Selling & Marketing	$0
General & Administrative	$1.4B
SG&A Expenses	$1.4B
Other Expenses	$0
Operating Expenses	$2.7B
Cost & Expenses	$3.8B
OPERATING INCOME	$1.5B
Interest Income	$32M
Interest Expense	$61M
Other Income/Expenses	-$137M
INCOME BEFORE TAX	$1.3B
Income Tax Expense	$248M
Net Income from Continuing Ops	$1.1B
Net Income from Discontinued Ops	$56M
Other Adjustments	$0
NET INCOME	$1.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.1B
D&A	$416M
EBIT	$1.4B
EBITDA	$1.8B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$5.3B
Cost of Revenue	$1.2B
GROSS PROFIT	$4.2B
R&D Expenses	$1.3B
Selling & Marketing	$0
General & Administrative	$1.4B
SG&A Expenses	$1.4B
Other Expenses	$0
Operating Expenses	$2.7B
Cost & Expenses	$3.8B
OPERATING INCOME	$1.5B
Interest Income	$32M
Interest Expense	$61M
Other Income/Expenses	-$137M
INCOME BEFORE TAX	$1.3B
Income Tax Expense	$248M
Net Income from Continuing Ops	$1.1B
Net Income from Discontinued Ops	$56M
Other Adjustments	$0
NET INCOME	$1.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.1B
D&A	$416M
EBIT	$1.4B
EBITDA	$1.8B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$1.1B
Depreciation & Amortization	$416M
Stock-Based Compensation	$69M
Deferred Income Tax	$27M
Other Non-Cash Items	$168M
Change in Working Capital	$294M
OPERATING CASH FLOW	$2.1B
Capital Expenditure	-$300M
Acquisitions (Net)	-$30M
Purchases of Investments	-$43M
Sales/Maturities of Investments	$88M
Other Investing Activities	-$114M
NET CASH FROM INVESTING	-$398M
Net Debt Issuance	$429M
Common Stock Repurchased	-$1.0B
Common Dividends Paid	-$573M
Other Financing Activities	-$84M
NET CASH FROM FINANCING	$433M
FREE CASH FLOW	$1.8B
Net Change in Cash	$2.1B

Balance Sheet

Item	Amount
Cash & Equivalents	$9.0B
Short-Term Investments	$76M
Net Receivables	$5.7B
Inventory	$4.1B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$20.7B
PP&E (Net)	$8.8B
Goodwill	$4.4B
Intangible Assets	$3.6B
Long-Term Investments	$2.0B
Tax Assets	$3.1B
Other Non-Current Assets	$2.0B
TOTAL NON-CURRENT ASSETS	$23.9B
TOTAL ASSETS	$44.6B
Account Payables	$1.3B
Short-Term Debt	$1.0B
Deferred Revenue	$0
Other Current Liabilities	$7.3B
TOTAL CURRENT LIABILITIES	$10.8B
Long-Term Debt	$11.7B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$8.0B
TOTAL NON-CURRENT LIABILITIES	$19.6B
TOTAL LIABILITIES	$30.5B
Common Stock	$667M
Additional Paid-In Capital	$6.5B
Retained Earnings	$14.4B
Treasury Stock	-$69M
Accum. Other Comp. Income	-$5.4B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$13.1B
Minority Interest	$1.1B
TOTAL EQUITY	$14.2B
TOTAL LIABILITIES & EQUITY	$44.6B
Total Debt	$12.7B
Net Debt	$3.7B